Department of Biostatistics and Translational Medicine
Project
We are pleased to announce that Damian Mikulski, a member of our Department, is among the 40 recipients of research scholarships awarded in the 4th edition of the Walczak NAWA program. Starting in February 2025, Dr. Mikulski will spend five months working with Professor Robert Orlowski, M.D., Ph.D., at the University of Texas MD Anderson […]
We are pleased to announce that Grzegorz Mirocha, a student from the Department of Biostatistics and Translational Medicine, has received funding of PLN 30,000 under the “UMed grants” program for his project “Exploring NRP2 and MDK as serum markers for predicting poor mobilization in multiple myeloma patients treated with anti-CD38 monoclonal antibody-based induction therapy”. The […]
On May 10, 2024, two of our scientists, Zuzanna Nowicka, M.D., and Arkadiusz Michalak, M.D., received START scholarships. The START program of the Foundation for Polish Science is the largest scholarship program in Poland for the best young scientists representing all fields of science. Its purpose is to support outstanding young scientists and encourage them […]
We are pleased to inform you that the project ‘Radonek-AI – virtual assistant for oncological patients’ has been granted 70,000.00 PLN as part of the ‘Student Scientific Associations Creating Innovations’ initiative. The project will be carried out by members of the Student Scientific Association of Artificial Intelligence in Oncology, operating at the Department of Biostatistics […]
We are happy to announce that the miRPOC project (“miRPOC: miRNA as biomarkers in early detection and personalised treatment in ovarian cancer”) has been awarded funding under the ERA PerMed Joint Translational Call 2022, co-financed by the European Commission. This project is conducted within an international research consortium and aims to develop and validate a […]
We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]
In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]
We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from our team, titled “B cell depletion therapy to improve outcomes of steroid-sensitive nephrotic syndrome in adults – the BOOSTER trial,” has received funding recommendation in the second edition of the Medical Research Agency’s Head-to-Head Research […]
Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% of new cancer diagnoses worldwide. Approximately 5% – 10% of cases involve hereditary breast and ovarian cancer (HBOC), most commonly linked to mutations in the BRCA1 or BRCA2 genes. Currently, BRCA1/2 genetic tests are recommended […]
We are excited to share that Dr. Monika Anna Golińska has been awarded the NCN “MSCA POLONEZ BIS 3” grant for her project titled “ENDOVO: Identifying biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging and data mining.” The project will be conducted at the Department of Biostatistics and Translational Medicine. Endometriosis is a condition where […]
